๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Clinical singgnificance of interactions with antifungal agents

โœ Scribed by A. BRECKENDRIDGE

Book ID
108662114
Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
342 KB
Volume
126
Category
Article
ISSN
0007-0963

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Drug interactions of the newer oral anti
Drug interactions of the newer oral antifungal agents
โœ Katz ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 111 KB

The newer oral antifungal agents, such as fluconazole, itraconazole and terbinafine, are generally both effective and well tolerated in the management of widespread or resistant dermatomycoses such as onychomycosis. However, these agents differ markedly in their potential to cause clinically signifi

Interactions of azole antifungal agents
Interactions of azole antifungal agents with the human breast cancer resistance protein (BCRP)
โœ Anshul Gupta; Jashvant D. Unadkat; Qingcheng Mao ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 169 KB

Breast cancer resistance protein (BCRP) is an efflux transporter that plays an important role in drug disposition. The goal of this study was to investigate the interactions of azole antifungal agents, ketoconazole, itraconazole, fluconazole, and voriconazole, with BCRP. First, the effect of the azo